630-580-1088 sales@ambeed.com
Structure Search

List Search MOL Search Structure Search

0
Chemistry
Asymmetric Synthesis >>Chiral Building BlocksChiral Catalysts, Chiral Ligands and Chiral ReagentsChiral Resolution ReagentsBoronic acids/esters >>Aliphatic BoronsAromatic BoronsOther BoronsOxaborolesCatalysis Chemistry >>Achiral Crown LigandsC-H ActivationCarbon-Donor LigandsChiral Carbon LigandsChiral Crown LigandsChiral Olefin LigandsCross-CouplingCross-Coupling Using Transition Metal CatalystsDACH or Trost LigandsChemical Biology >>Conjugation Chemistry
GlycoscienceLinkers and CrosslinkersNucleic Acid ChemistryPEGylationPeptide ChemistryPhotolabile Protecting GroupHeterocyclic Building Blocks >>AcridinesAliphatic HeterocyclesAromatic HeterocyclesAzetidinesBenzimidazolesBenzisoxazolesBenzodioxansBenzofuransBenzothiazolesInorganic reagents >>Inorganic reagentOrganic Building Blocks >>Acid AnhydridesAcyl Chlorides
AlcoholsAldehydesAliphatic Chain HydrocarbonsAliphatic Cyclic HydrocarbonsAlkenesAlkylsAlkynesOrganometallic Reagents >>Grignard ReagentsOrganoarsenicOrganobismuthOrganoboronOrganogermaniumOrganolithiumOrganomercuryOrganosiliconOrganotinSpecialty Synthesis >>Enzyme-Mediated SynthesisFluorous SynthesisIonic Liquids
Solid Supported SynthesisStains and Dyes >>Acid DyesAzoic DyesBasic DyesDirect DyesDisperse DyesDye IntermediatesMordant DyesOil DyesOther Stains and DyesSynthetic Reagents >>Acids and BasesC-C Bond FormationC-X Bond Formation (Halogen)C-X Bond Formation (Non-Halogen)Chelation and Complexation CompoundsCondensation AgentsCouplingDehydrating ReagentsFluorination Reagent
Pharmaceutical Intermediates
Analgesics >>BenzhydrocodoneBicifadineCapsaicinCelecoxibDebio-0827DexamethasoneElagolix SodiumEsketamine HydrochlorideIbuprofen sodiumAnesthetics >>CiprofolEsketamine HydrochlorideFospropofol Fospropofol DisodiumLevobupivacaine RemimazolamRemimazolam BesilateRemimazolam besylateRopivacaineAnti-Addiction Agents >>Kakonein
Lofexidine HydrochlorideVarenicline Anti-inflammatory Agents >>ApremilastAsunaprevirATB-346 RelatedBalsalazide BaricitinibBencycloquidium BromideBudesonideCefiderocol Sulfate TosylateCeftaroline Fosamil AcetateAntibacterials >>AFN-1252 RelatedAlatrofloxacin Bedaquiline FumarateBesifloxacin BrilacidinCaspofungin AcetateCefiderocol Sulfate TosylateCefilavancinCeftaroline Fosamil
Anticonvulsants >>BrivaracetamCannabidiolEscitalopram OxalateEslicarbazepine Acetate RelatedFosphenytoinGabapentin EnacarbilJNJ-10234094LacosamideLevetiracetam RelatedAntidementia Agents >>Azeliragon RelatedDavunetideDonepezil HydrochlorideDonepezil RelatedEnsaculinFlorbetaben Flortaucipir F 18Flutemetamol IdalopirdineAntidepressants >>4-Chlorokynurenine
AgomelatineAgomelatine RelatedAllopregnanolone RelatedAmibegronAmitifadineAripiprazole RelatedBasimglurantBefloxatoneAntiemetics >>AprepitantAprepitant RelatedDolasetron RelatedDolasetron Mesylate HydrateFosaprepitant DimeglumineFosaprepitant RelatedOlanzapinePalonosetron RelatedPalonosetron HydrochlorideAntifungals >>Anidulafungin RelatedCabotegravirMore >>
Inhibitors/Agonists
ADC >>ADC AntibodyADC LinkerADC Linker with PayloadADC ToxinAntibody-Drug Conjugates (ADCs)Drug-Linker Conjugates for ADCAngiogenesis >>ALKBcr-AblBTKEGFRFAKFGFRFLT3HER2HIFAnti-infection >>3CLproAntibacterialAntibioticAntifungal
AntiparasiticAntiprotozoalAntiviralArenavirusBVDVApoptosis >>Apoptosis InducerBcl-2Bcl-6BRKc-Mycc-RETC/EBPCARDCaspaseAutophagy >>Atg4ATG4BATTECsAUTACsAutophagyBeclin1
FKBPLC3LRRK2Biochemical Reagent >>Cell Cycle >>AntifolateAPCAurora KinaseBUBCasein KinaseCdc25CDKChkCRISPR/Cas9Cytoskeleton >>ActinArp2/3 ComplexCYTHCytoplasmic dyneinDynaminFAKMore >>
Material Science
Aggregation-Induced Emission >>Other AIE BlocksTetraphenylethylene SeriesCOFs Linkers >>Aldehyde COFs LinkersAlkynyl COFs LinkersAmine COFs LinkersBoric COFs LinkersCyano COFs LinkersMultifunctional COFs linkersOther COFs linkersTriphene seriesElectronic Materials >>Battery MaterialsDye-Sensitized Solar Cell (DSSC) MaterialsElectronic MaterialLiquid Crystal (LC) MaterialsMolecular ConductorsOrganic Light-Emitting Diode (OLED) MaterialsOrganic Solar Cell (OPV) MaterialsOrganic Transistor (OFET) MaterialsPerovskite Solar Cell (PSC) MaterialsMagnetic Materials >>Magnetic Ionic LiquidsMagnetic MaterialMagnetic Metal Complexes
Organic Radicals Material Chemical Compounds >>Ligands for Functional Metal ComplexesLiquid Crystal (LC) Building BlocksPhthalocyanine Building BlocksPolymer and Macromolecule Semiconductor Building BlocksSmall Molecule Semiconductor Building BlocksSolubility Enhancing Reagents Supramolecular Host Materials MOF Ligands >>Carboxylic Acid MOF LigandsCarboxylic Acid Nitrogen-Containing Mixed MOF LigandsNitrogen-Containing MOF LigandsOther MOF ligandsNanomaterials >>Carbon NanomaterialsCeramic MembranesDendrimersGold NanoparticlesIron Oxide NanoparticlesMaterials by ApplicationMesoporous MaterialsMetals and Metal AlloysNano Minerals: NanoclaysOLED Materials >>Dopant
HostHTMOLED IntermediatesOther OLED related materialsOptical Materials >>Coumarin DyesCyanine and Squarylium DyesDCM DyesDipyrromethene DyesFluorescence MaterialsFluorescent ProbesHeat and Pressure Sensitive DyesNear-Infrared (NIR) DyesOrganic Non-Linear Optical (NLO) MaterialsOrganic Pigments >>Organic PigmentOther Materials >>Mateial OtherPolymer Science >>MonomersPolymer AdditivesPolymerization ReagentsPolymersResins
Contact Us
Home Cart 0 Sign in  
Chemistry
Organic Building Blocks
Carboxylic Acids
Fmoc-Bpa-OH
Chemistry
Life Science
Organic Building Blocks
Amino Acids
Carboxylic Acids
Carbamates Benzene Compounds Amino Acid Derivatives

[ CAS No. 117666-96-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 117666-96-3
Chemical Structure| 117666-96-3
Structure of 117666-96-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 110K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 117666-96-3 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 117666-96-3 ]

SDS Specification
Alternatived Products of [ 117666-96-3 ]

Product Details of [ 117666-96-3 ]

CAS No. :117666-96-3 MDL No. :MFCD00151937
Formula : C31H25NO5 Boiling Point : -
Linear Structure Formula :- InChI Key :SYOBJKCXNRQOGA-NDEPHWFRSA-N
M.W : 491.53 Pubchem ID :14233360
Synonyms :

Calculated chemistry of [ 117666-96-3 ]

Physicochemical Properties

Num. heavy atoms : 37
Num. arom. heavy atoms : 24
Fraction Csp3 : 0.13
Num. rotatable bonds : 10
Num. H-bond acceptors : 5.0
Num. H-bond donors : 2.0
Molar Refractivity : 139.53
TPSA : 92.7 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.05 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.96
Log Po/w (XLOGP3) : 5.99
Log Po/w (WLOGP) : 5.45
Log Po/w (MLOGP) : 3.72
Log Po/w (SILICOS-IT) : 5.59
Consensus Log Po/w : 4.74

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -6.48
Solubility : 0.000162 mg/ml ; 0.00000033 mol/l
Class : Poorly soluble
Log S (Ali) : -7.71
Solubility : 0.0000095 mg/ml ; 0.0000000193 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -9.74
Solubility : 0.000000089 mg/ml ; 0.0000000002 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 4.11

Safety of [ 117666-96-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 117666-96-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 117666-96-3 ]

[ 117666-96-3 ] Synthesis Path-Downstream   1~45

  • 1
  • [ 117666-96-3 ]
  • [ 655224-07-0 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
68% With 4-methyl-morpholine; 1-hydroxybenzotriazol-hydrate; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane
Reference： [1]Hagenstein, Miriam C.; Mussgnug, Jan H.; Lotte, Kirsten; Plessow, Regina; Brockhinke, Andreas; Kruse, Olaf; Sewald, Norbert [Angewandte Chemie - International Edition, 2003, vol. 42, # 45, p. 5635 - 5638]
  • 2
  • [ 110-89-4 ]
  • [ 425393-71-1 ]
  • [ CAS Unavailable ]
  • [ 117666-96-3 ]
  • [ 425393-79-9 ]
YieldReaction ConditionsOperation in experiment
With benzotriazol-1-ol In methanol; dichloromethane; water 62 2-Amino-3-(4-benzoyl-phenyl)-N-{3-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-pyridin-2-yl-ethyl]-benzyl}propionamide Example 62 2-Amino-3-(4-benzoyl-phenyl)-N-{3-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-pyridin-2-yl-ethyl]-benzyl}propionamide N-Fmoc-4-benzoylphenylalanine (1 mmol, 491 mg) was mixed with HOBT,H2O (1 mmol, 153 mg) in dichloromethane (20 mL); EDAC,HCl (1.1 mmol, 200 mg) was added and the mixture stirred under nitrogen at room temperature for 2 h. 3-[2-(4,5-Dihydro-1H-imidazol-2-yl)-1-pyridin-2-yl-ethyl]benzylamine (1 mmol, 280 mg) in dichloromethane (4 mL) was added and the mixture stirred overnight at room temperature. The solvent was subsequently evaporated and the residue treated with piperidine:methanol (1:4) (20 mL) by stirring at room temperature for 30 min. The solvent was evaporated and the residue extracted between NaOH (1 M) and dichloromethane. The organic layers were collected and evaporated to give an oil. Treatment with methanol caused crystallisation of Fmoc-piperidine, which was isolated by filtration and discarded. The filtrate was purified on a silica gel column yielding 2-amino-3-(4-benzoyl-phenyl)-N-{3-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-pyridin-2-yl-ethyl]benzyl}propionam ide (220 mg) as an oil. LCMS: m/z (M+1)+532. Retention time: 1.92 min, purity (ELS) 95%.
Reference： [1]Current Patent Assignee: NOVO NORDISK A/S - US2002/132812, 2002, A1
  • 3
  • [ 53293-00-8 ]
  • [ 88574-06-5 ]
  • 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid [ No CAS ]
  • [ 185116-43-2 ]
  • [ 1011719-43-9 ]
Reference： [1]Journal of the American Chemical Society,2008,vol. 130,p. 2184 - 2194
  • 4
  • [ 53293-00-8 ]
  • [ 149834-58-2 ]
  • 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid [ No CAS ]
  • [ 185116-43-2 ]
  • methyl-8-chloro-8-oxooctanoate [ No CAS ]
  • C44H54N4O7 [ No CAS ]
Reference： [1]Journal of the American Chemical Society,2008,vol. 130,p. 2184 - 2194
  • 5
  • [ 53293-00-8 ]
  • [ 164470-64-8 ]
  • 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid [ No CAS ]
  • [ 1011719-33-7 ]
Reference： [1]Journal of the American Chemical Society,2008,vol. 130,p. 2184 - 2194
  • 6
  • [ 53293-00-8 ]
  • [ 164470-64-8 ]
  • 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid [ No CAS ]
  • C30H28N2O5 [ No CAS ]
Reference： [1]Journal of the American Chemical Society,2008,vol. 130,p. 2184 - 2194
  • 7
  • [ 53293-00-8 ]
  • 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid [ No CAS ]
  • [ 185116-43-2 ]
  • [ 1011719-39-3 ]
Reference： [1]Journal of the American Chemical Society,2008,vol. 130,p. 2184 - 2194
  • 8
  • [ 53293-00-8 ]
  • 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid [ No CAS ]
  • [ 185116-43-2 ]
  • C29H26N2O5 [ No CAS ]
Reference： [1]Journal of the American Chemical Society,2008,vol. 130,p. 2184 - 2194
  • 9
  • [ 41624-92-4 ]
  • [ 102169-54-0 ]
  • 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid [ No CAS ]
  • C31H38N2O5 [ No CAS ]
YieldReaction ConditionsOperation in experiment
Multistep reaction.;
Reference： [1]Salisbury, Cleo M.; Cravatt, Benjamin F. [Journal of the American Chemical Society, 2008, vol. 130, # 7, p. 2184 - 2194]
  • 10
  • [ 41624-92-4 ]
  • [ 102169-54-0 ]
  • 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid [ No CAS ]
  • [ 185116-43-2 ]
  • C38H43N3O6 [ No CAS ]
Reference： [1]Journal of the American Chemical Society,2008,vol. 130,p. 2184 - 2194
  • 11
  • [ CAS Unavailable ]
  • [ 117666-96-3 ]
  • [ 1124322-52-6 ]
YieldReaction ConditionsOperation in experiment
90% With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 24h;
Reference： [1]Moretto, Alessandro; Crisma, Marco; Formaggio, Fernando; Huck, Lawrence A.; Mangion, Dino; Leigh, William J.; Toniolo, Claudio [Chemistry - A European Journal, 2009, vol. 15, # 1, p. 67 - 70]
  • 12
  • [ CAS Unavailable ]
  • [ 117666-96-3 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
With 1-hydroxy-7-aza-benzotriazole; diisopropyl-carbodiimide In 1-methyl-pyrrolidin-2-one at 20℃; solid phase reaction;
Reference： [1]Location in patent: scheme or table Jin, Jian; Wang, Yonghui; Shi, Dongchuan; Wang, Feng; Fu, Wei; Davis, Roderick S.; Jin, Qi; Foley, James J.; Sarau, Henry M.; Morrow, Dwight M.; Moore, Michael L.; Rivero, Ralph A.; Palovich, Michael; Salmon, Michael; Belmonte, Kristen E.; Busch-Petersen, Jakob [Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 20, p. 5481 - 5486]
  • 13
  • [ CAS Unavailable ]
  • [ 117666-96-3 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
With benzotriazol-1-ol; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine at 20℃; for 0.5h; solid phase reaction;
Reference： [1]Location in patent: experimental part Harbut, Michael B.; Velmourougane, Geetha; Reiss, Gilana; Chandramohanadas, Rajesh; Greenbaum, Doron C. [Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 22, p. 5932 - 5936]
  • 14
  • [ CAS Unavailable ]
  • [ 117666-96-3 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
With benzotriazol-1-ol; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 0.5h; solid phase reaction;
Reference： [1]Location in patent: experimental part Harbut, Michael B.; Velmourougane, Geetha; Reiss, Gilana; Chandramohanadas, Rajesh; Greenbaum, Doron C. [Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 22, p. 5932 - 5936]
  • 15
  • [ CAS Unavailable ]
  • [ 117666-96-3 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
With benzotriazol-1-ol; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine at 20℃; for 0.5h; solid phase reaction;
Reference： [1]Location in patent: scheme or table Harbut, Michael B.; Velmourougane, Geetha; Reiss, Gilana; Chandramohanadas, Rajesh; Greenbaum, Doron C. [Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 22, p. 5932 - 5936]
  • 16
  • [ CAS Unavailable ]
  • [ 117666-96-3 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
With benzotriazol-1-ol; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 0.5h; solid phase reaction;
Reference： [1]Location in patent: experimental part Harbut, Michael B.; Velmourougane, Geetha; Reiss, Gilana; Chandramohanadas, Rajesh; Greenbaum, Doron C. [Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 22, p. 5932 - 5936]
  • 17
  • [ CAS Unavailable ]
  • [ 117666-96-3 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
With 4-methyl-morpholine; (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; benzotriazol-1-ol In N,N-dimethyl-formamide for 1.5h; solid phase reaction;
Reference： [1]Location in patent: experimental part Lavogina, Darja; Lust, Marje; Viil, Indrek; König, Norbert; Raidaru, Gerda; Rogozina, Jevgenia; Enkvist, Erki; Uri, Asko; Bossemeyer, Dirk [Journal of Medicinal Chemistry, 2009, vol. 52, # 2, p. 308 - 321]
  • 18
  • [ 910297-59-5 ]
  • [ 117666-96-3 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
88.9% With benzotriazol-1-ol; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine at 20℃; Inert atmosphere;
Reference： [1]Location in patent: experimental part Shi, Haibin; Zhang, Chong-Jing; Chen, Grace Y. J.; Yao, Shao Q. [Journal of the American Chemical Society, 2012, vol. 134, # 6, p. 3001 - 3014]
  • 19
  • [ CAS Unavailable ]
  • [ 71989-28-1 ]
  • [ 117666-96-3 ]
  • [ 1960446-61-0 ]
YieldReaction ConditionsOperation in experiment
Stage #1: C11H9N2O3Pol; 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid With 2,4,6-trimethyl-pyridine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane; N,N-dimethyl-formamide Stage #2: With piperidine In N,N-dimethyl-formamide Stage #3: N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-methionine Further stages;
Reference： [1]Poreba, Marcin; Mihelic, Marko; Krai, Priscilla; Rajkovic, Jelena; Krezel, Artur; Pawelczak, Malgorzata; Klemba, Michael; Turk, Dusan; Turk, Boris; Latajka, Rafal; Drag, Marcin [Amino Acids, 2014, vol. 46, # 4, p. 931 - 943]
  • 20
  • [ 1229035-97-5 ]
  • [ 117666-96-3 ]
  • [ 1827586-65-1 ]
YieldReaction ConditionsOperation in experiment
80% Stage #1: 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid With benzotriazol-1-ol; 1,2-dichloro-ethane In dichloromethane; N,N-dimethyl-formamide at 20℃; for 1h; Molecular sieve; Inert atmosphere; Stage #2: 7a-(4-aminobutyl)-2-{4-[4-(1-naphthyl)piperazin-1-yl]butyl}tetrahydro-1H-pyrrolo[1,2-c]imidazole-1,3(2H)-dione In dichloromethane at 20℃; for 72h; Inert atmosphere;
Reference： [1]Gamo, Ana M.; González-Vera, Juan A.; Rueda-Zubiaurre, Ainoa; Alonso, Dulce; Vázquez-Villa, Henar; Martín-Couce, Lidia; Palomares, Óscar; Lõpez, Juan A.; Martín-Fontecha, Mar; Benhamú, Bellinda; Lõpez-Rodríguez, María L.; Ortega-Gutiérrez, Silvia [Chemistry - A European Journal, 2016, vol. 22, # 4, p. 1313 - 1321]
  • 21
  • [ 117666-96-3 ]
  • [ 1827586-66-2 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1.1: benzotriazol-1-ol; 1,2-dichloro-ethane / N,N-dimethyl-formamide; dichloromethane / 1 h / 20 °C / Molecular sieve; Inert atmosphere 1.2: 72 h / 20 °C / Inert atmosphere 2.1: piperidine / dichloromethane / 2 h / 0 °C / Inert atmosphere 2.2: Inert atmosphere
Reference： [1]Gamo, Ana M.; González-Vera, Juan A.; Rueda-Zubiaurre, Ainoa; Alonso, Dulce; Vázquez-Villa, Henar; Martín-Couce, Lidia; Palomares, Óscar; Lõpez, Juan A.; Martín-Fontecha, Mar; Benhamú, Bellinda; Lõpez-Rodríguez, María L.; Ortega-Gutiérrez, Silvia [Chemistry - A European Journal, 2016, vol. 22, # 4, p. 1313 - 1321]
  • 22
  • [ 117666-96-3 ]
  • [ 1827586-41-3 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 3 steps 1.1: benzotriazol-1-ol; 1,2-dichloro-ethane / N,N-dimethyl-formamide; dichloromethane / 1 h / 20 °C / Molecular sieve; Inert atmosphere 1.2: 72 h / 20 °C / Inert atmosphere 2.1: piperidine / dichloromethane / 2 h / 0 °C / Inert atmosphere 2.2: Inert atmosphere 3.1: dmap; dicyclohexyl-carbodiimide / dichloromethane / 0.5 h / 0 °C / Inert atmosphere 3.2: 72 h / 20 °C / Inert atmosphere
Reference： [1]Gamo, Ana M.; González-Vera, Juan A.; Rueda-Zubiaurre, Ainoa; Alonso, Dulce; Vázquez-Villa, Henar; Martín-Couce, Lidia; Palomares, Óscar; Lõpez, Juan A.; Martín-Fontecha, Mar; Benhamú, Bellinda; Lõpez-Rodríguez, María L.; Ortega-Gutiérrez, Silvia [Chemistry - A European Journal, 2016, vol. 22, # 4, p. 1313 - 1321]
  • 23
  • [ 117666-96-3 ]
  • [ 1916487-93-8 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 3 steps 1: N-ethyl-N,N-diisopropylamine; HATU / N,N-dimethyl-formamide / 1 h / 0 °C / Inert atmosphere 2: piperidine / dichloromethane / 20 °C / Inert atmosphere 3: N-ethyl-N,N-diisopropylamine; HATU / N,N-dimethyl-formamide / 1 h / 20 °C / Inert atmosphere
Reference： [1]Park, Hankum; Koo, Ja Young; Srikanth, Yellamelli V. V.; Oh, Sangmi; Lee, Jiyoon; Park, Jongmin; Park, Seung Bum [Chemical Communications, 2016, vol. 52, # 34, p. 5828 - 5831]
  • 24
  • [ 117666-96-3 ]
  • [ 2035120-49-9 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: N-ethyl-N,N-diisopropylamine; HATU / N,N-dimethyl-formamide / 1 h / 0 °C / Inert atmosphere 2: piperidine / dichloromethane / 20 °C / Inert atmosphere
Reference： [1]Park, Hankum; Koo, Ja Young; Srikanth, Yellamelli V. V.; Oh, Sangmi; Lee, Jiyoon; Park, Jongmin; Park, Seung Bum [Chemical Communications, 2016, vol. 52, # 34, p. 5828 - 5831]
  • 25
  • [ 117666-96-3 ]
  • [ 2035120-51-3 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 4 steps 1: N-ethyl-N,N-diisopropylamine; HATU / N,N-dimethyl-formamide / 1 h / 0 °C / Inert atmosphere 2: piperidine / dichloromethane / 20 °C / Inert atmosphere 3: N-ethyl-N,N-diisopropylamine; HATU / N,N-dimethyl-formamide / 1 h / 20 °C / Inert atmosphere 4: dichloromethane / 12 h / 20 °C / Inert atmosphere
Reference： [1]Park, Hankum; Koo, Ja Young; Srikanth, Yellamelli V. V.; Oh, Sangmi; Lee, Jiyoon; Park, Jongmin; Park, Seung Bum [Chemical Communications, 2016, vol. 52, # 34, p. 5828 - 5831]
  • 26
  • [ 117666-96-3 ]
  • [ 1916487-96-1 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 5 steps 1: N-ethyl-N,N-diisopropylamine; HATU / N,N-dimethyl-formamide / 1 h / 0 °C / Inert atmosphere 2: piperidine / dichloromethane / 20 °C / Inert atmosphere 3: N-ethyl-N,N-diisopropylamine; HATU / N,N-dimethyl-formamide / 1 h / 20 °C / Inert atmosphere 4: dichloromethane / 12 h / 20 °C / Inert atmosphere 5: 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine; benzotriazol-1-ol / 1,4-dioxane / 12 h / 20 °C / Inert atmosphere
Reference： [1]Park, Hankum; Koo, Ja Young; Srikanth, Yellamelli V. V.; Oh, Sangmi; Lee, Jiyoon; Park, Jongmin; Park, Seung Bum [Chemical Communications, 2016, vol. 52, # 34, p. 5828 - 5831]
  • 27
  • [ CAS Unavailable ]
  • [ 117666-96-3 ]
  • [ 1916488-01-1 ]
YieldReaction ConditionsOperation in experiment
With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide at 0℃; for 1h; Inert atmosphere;
Reference： [1]Park, Hankum; Koo, Ja Young; Srikanth, Yellamelli V. V.; Oh, Sangmi; Lee, Jiyoon; Park, Jongmin; Park, Seung Bum [Chemical Communications, 2016, vol. 52, # 34, p. 5828 - 5831]
  • 28
  • [ 1918-77-0 ]
  • [ CAS Unavailable ]
  • [ 71989-31-6 ]
  • [ 35737-15-6 ]
  • [ 76-05-1 ]
  • [ 117666-96-3 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
25% Stage #1: Fmoc-L-Asn-OH With benzotriazol-1-ol; diisopropyl-carbodiimide In N,N-dimethyl-formamide for 2h; Stage #2: With piperidine In N,N-dimethyl-formamide Stage #3: Thiophene-2-acetic acid; Fmoc-Pro-OH; Fmoc-Trp-OH; trifluoroacetic acid; 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid; Fmoc-Arg(pg)-OH
Reference： [1]Takayama, Kentaro; Mori, Kenji; Tanaka, Akiko; Nomura, Erina; Sohma, Yuko; Mori, Miwa; Taguchi, Akihiro; Taniguchi, Atsuhiko; Sakane, Toshiyasu; Yamamoto, Akira; Minamino, Naoto; Miyazato, Mikiya; Kangawa, Kenji; Hayashi, Yoshio [Journal of Medicinal Chemistry, 2017, vol. 60, # 12, p. 5228 - 5234]
  • 29
  • [ 117666-96-3 ]
  • [ 2305312-92-7 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1.1: N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate / dichloromethane / 0.5 h 1.2: 6 h / 20 °C 2.1: piperidine / dichloromethane / 0.5 h
Reference： [1]Stoddard, Ethan G.; Killinger, Bryan J.; Nair, Reji N.; Sadler, Natalie C.; Volk, Regan F.; Purvine, Samuel O.; Shukla, Anil K.; Smith, Jordan N.; Wright, Aaron T. [Journal of the American Chemical Society, 2017, vol. 139, # 45, p. 16032 - 16035]
  • 30
  • [ 117666-96-3 ]
  • [ 2305312-93-8 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 3 steps 1.1: N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate / dichloromethane / 0.5 h 1.2: 6 h / 20 °C 2.1: piperidine / dichloromethane / 0.5 h 3.1: dichloromethane / 0.25 h / 20 °C
Reference： [1]Stoddard, Ethan G.; Killinger, Bryan J.; Nair, Reji N.; Sadler, Natalie C.; Volk, Regan F.; Purvine, Samuel O.; Shukla, Anil K.; Smith, Jordan N.; Wright, Aaron T. [Journal of the American Chemical Society, 2017, vol. 139, # 45, p. 16032 - 16035]
  • 31
  • [ 117666-96-3 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 4 steps 1.1: N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate / dichloromethane / 0.5 h 1.2: 6 h / 20 °C 2.1: piperidine / dichloromethane / 0.5 h 3.1: dichloromethane / 0.25 h / 20 °C 4.1: aq. phosphate buffer / 20 °C / pH 7.2
Reference： [1]Stoddard, Ethan G.; Killinger, Bryan J.; Nair, Reji N.; Sadler, Natalie C.; Volk, Regan F.; Purvine, Samuel O.; Shukla, Anil K.; Smith, Jordan N.; Wright, Aaron T. [Journal of the American Chemical Society, 2017, vol. 139, # 45, p. 16032 - 16035]
  • 32
  • [ 117666-96-3 ]
  • [ CAS Unavailable ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
Stage #1: 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane for 0.5h; Stage #2: Propargylamine In dichloromethane at 20℃; for 6h;
Reference： [1]Stoddard, Ethan G.; Killinger, Bryan J.; Nair, Reji N.; Sadler, Natalie C.; Volk, Regan F.; Purvine, Samuel O.; Shukla, Anil K.; Smith, Jordan N.; Wright, Aaron T. [Journal of the American Chemical Society, 2017, vol. 139, # 45, p. 16032 - 16035]
  • 33
  • [ 29022-11-5 ]
  • [ 35661-60-0 ]
  • [ 35661-40-6 ]
  • [ 71989-16-7 ]
  • [ 112667-29-5 ]
  • [ 73724-45-5 ]
  • [ 117666-96-3 ]
  • [ 58-85-5 ]
  • [ 2131089-40-0 ]
YieldReaction ConditionsOperation in experiment
Stage #1: N-(9-fluorenylmethoxycarbonyl)-L-phenylalaninamide With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate Automated synthesizer; Stage #2: With piperidine In N,N-dimethyl-formamide Automated synthesizer; Stage #3: N-(fluoren-9-ylmethoxycarbonyl)glycine; Fmoc-Leu-OH; N-Fmoc L-Phe; Fmoc-Asn-OH; N-(9H-fluoren-9-ylmethoxycarbonyl)-L-serine; 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid; biotin; Fmoc-Arg(pg)-OH; Fmoc-Trp(pg)-OH Further stages; Peptide Synthesis General procedure: The different kisspeptin-10 peptides were synthesized by standard Fmoc-based solid-phase peptide synthesis on a Syro II automated peptide synthesizer (Multisyntech), using either Rink Amide AM (200-400 mesh) or Rink Amide ChemMatrix as solid support. The peptide chain was assembled using HBTU as coupling reagent. For Fmoc-deprotection, a 3′ treatment with 40% piperidine in DMF was used, followed by a 12′ treatment with 20% piperidine in DMF. The furan and benzophenone moiety were introduced using the commercially available unnatural amino acids Fmoc--(2-furyl)-Ala-OH and Fmoc-L-4-Benzoylphenylalanine-OH. These amino acids were coupled manually to the peptide chain using COMU as coupling reagent. (0386) All peptides were biotinylated after automated synthesis using either biotin or biotin-dPEG(4)-COOH, with COMU as coupling reagent in the presence of DIPEA. Peptides were cleaved off with TFA/TIS/H2O (95/2.5/2.5) during 2 h and precipitated with cold methyl tert-butyl ether and analysed by RP-HPLC and ESI-MS or MALDI-MS
Reference： [1]Current Patent Assignee: GHENT UNIVERSITY - US10753944, 2020, B2 Location in patent: Page/Page column 39-41
  • 34
  • [ 29022-11-5 ]
  • [ 35661-60-0 ]
  • [ 35661-40-6 ]
  • [ 71989-16-7 ]
  • [ 112667-29-5 ]
  • [ 73724-45-5 ]
  • [ 117666-96-3 ]
  • [ 58-85-5 ]
  • [ 2131089-38-6 ]
YieldReaction ConditionsOperation in experiment
Stage #1: N-(9-fluorenylmethoxycarbonyl)-L-phenylalaninamide With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate Automated synthesizer; Stage #2: With piperidine In N,N-dimethyl-formamide Automated synthesizer; Stage #3: N-(fluoren-9-ylmethoxycarbonyl)glycine; Fmoc-Leu-OH; N-Fmoc L-Phe; Fmoc-Asn-OH; N-(9H-fluoren-9-ylmethoxycarbonyl)-L-serine; 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid; biotin; Fmoc-Arg(pg)-OH; Fmoc-Tyr-O(*) Further stages; Peptide Synthesis General procedure: The different kisspeptin-10 peptides were synthesized by standard Fmoc-based solid-phase peptide synthesis on a Syro II automated peptide synthesizer (Multisyntech), using either Rink Amide AM (200-400 mesh) or Rink Amide ChemMatrix as solid support. The peptide chain was assembled using HBTU as coupling reagent. For Fmoc-deprotection, a 3′ treatment with 40% piperidine in DMF was used, followed by a 12′ treatment with 20% piperidine in DMF. The furan and benzophenone moiety were introduced using the commercially available unnatural amino acids Fmoc--(2-furyl)-Ala-OH and Fmoc-L-4-Benzoylphenylalanine-OH. These amino acids were coupled manually to the peptide chain using COMU as coupling reagent. (0386) All peptides were biotinylated after automated synthesis using either biotin or biotin-dPEG(4)-COOH, with COMU as coupling reagent in the presence of DIPEA. Peptides were cleaved off with TFA/TIS/H2O (95/2.5/2.5) during 2 h and precipitated with cold methyl tert-butyl ether and analysed by RP-HPLC and ESI-MS or MALDI-MS
Reference： [1]Current Patent Assignee: GHENT UNIVERSITY - US10753944, 2020, B2 Location in patent: Page/Page column 39-41
  • 35
  • [ 29022-11-5 ]
  • [ 35661-60-0 ]
  • [ 35661-40-6 ]
  • [ 71989-14-5 ]
  • [ 108-24-7 ]
  • [ 71989-35-0 ]
  • [ 117666-96-3 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
Stage #1: Fmoc-Leu-OH With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate for 0.75h; Automated synthesizer; Stage #2: With piperidine In N,N-dimethyl-formamide Automated synthesizer; Stage #3: N-(fluoren-9-ylmethoxycarbonyl)glycine; Fmoc-Leu-OH; N-Fmoc L-Phe; Fmoc-(tBu)Asp-OH; acetic anhydride; Fmoc-Thr(tBu)-OH; 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid; Fmoc-Glu(Pg)-OH Further stages; General procedure: The amino acids (5eq) were activated with equimolar amounts of HATU and a 2-fold molar excess of DIPEA and acylated for 45min over the resin free amino groups. Fmoc deprotection in each coupling step and the end of the linear assembly was performed with 20% piperidine in (DMF). Acetylation of the N-terminus was performed by treating the resin in DMF with acetic anhydride (10eq) for 15min. The dry peptide-resin was treated with the cleavage mixture, 92.5% TFA, 2.5% TIPS and 5% H2O for 1h at RT. The resin was filtered off, the volatiles were evaporated by SpeedVac and the peptide precipitated by addition of cold MTBE. After removal of the supernatant, the peptide pellets were washed twice with MTBE, dried, taken into ACN/H2O and lyophilized. Lyophilization afforded crude peptides in yields ranging between 80 and 90%. The overall purity of the crude peptide was >90% as assessed by UPLC-MS analysis (Column: C18 ACQUITY BEH 1.7µm, 2.1x100 mm, 100Å, gradient: 10%-10% (1.5min)-60% (4min)-80% (1min) %B where A=H2O+0.1%TFA and B=ACN+0.1%TFA). The crude peptides were purified by RP-HPLC on an automated Waters FractionLynx RP-HPLC/MS using a Waters XBridge BEH C18 OBD Prep Column (130Å, 5µm, 30mm×150mm) at a flow rate of 30mL/min, λ=214nm, with a 10-10% (5min)-60%(20min) %B linear gradient (A=H2O+0.1%TFA and B=ACN+0.1%TFA). Purified peptides were recovered by lyophilization of pooled fractions with a purity>95% and yields ranging between 35 and 55%.
Reference： [1]Andreini, Matteo; Augustin, Martin; Bianchi, Elisabetta; Bresciani, Alberto; Cerretani, Mauro; Colarusso, Stefania; De Simone, Daniele; Dominguez, Celia; Frattarelli, Tommaso; Kempf, Georg; Missineo, Antonino; Moretti, Daniele; Munoz-Sanjuan, Ignacio; Park, Larry; Steinbacher, Stefan; Summa, Vincenzo; Tambone, Sara; Toledo-Sherman, Leticia; Tomei, Licia [Bioorganic and Medicinal Chemistry, 2020, vol. 28, # 21]
  • 36
  • [ 68858-20-8 ]
  • [ 2624118-11-0 ]
  • [ CAS Unavailable ]
  • [ 114360-54-2 ]
  • [ 84624-17-9 ]
  • [ 76-05-1 ]
  • [ 117666-96-3 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
Stage #1: C20H20NO3Pol With morpholine; 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl-formamide at 20℃; for 0.25h; Inert atmosphere; Stage #2: Fmoc-Val-OH With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane; N,N-dimethyl-formamide at 20℃; Inert atmosphere; Stage #3: Fmoc-L-Thz-(L-Val)-OH; N-(9-fluorenylmethoxycarbonyl)-D-leucine; N-(9-fluorenylmethoxycarbonyl)-D-valine; trifluoroacetic acid; 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid Further stages;
Reference： [1]Saur, Julian S.; Wirtz, Sebastian N.; Schilling, Nadine A.; Krismer, Bernhard; Peschel, Andreas; Grond, Stephanie [Journal of Medicinal Chemistry, 2021, vol. 64, # 7, p. 4034 - 4058]
  • 37
  • (2S)-4-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid [ No CAS ]
  • [ 6089-09-4 ]
  • [ 929-10-2 ]
  • [ 71989-35-0 ]
  • [ 125238-99-5 ]
  • 1‐fluorenylmethoxycarbonyl-(2S,3aS,7aS)‐octahydroindole‐2‐carboxylic acid [ No CAS ]
  • [ 135112-27-5 ]
  • (2S)-2-[9H-fluorene-9-ylmethoxycarbonylamino]-4-methylsulfonylbutanoic acid [ No CAS ]
  • 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid [ No CAS ]
  • C68H101N9O16S [ No CAS ]
YieldReaction ConditionsOperation in experiment
Stage #1: (2S)-4-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid With O‑(6‑chlorobezotriazol‑1‑yl)‑N,N,N,N‑tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h; Stage #2: With piperidine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 0.166667h; Stage #3: 4-pentynoic acid; isooctanoic acid; Fmoc-Thr(tBu)-OH; (S)-4-tert-butoxycarbonylamino-2-(9H-fluoren-9-ylmethoxycarbonylamino)butyric acid; 1‐fluorenylmethoxycarbonyl-(2S,3aS,7aS)‐octahydroindole‐2‐carboxylic acid; (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)butanoic acid; (2S)-2-[9H-fluorene-9-ylmethoxycarbonylamino]-4-methylsulfonylbutanoic acid; 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid Further stages;
Reference： [1]Beutling, Ulrike; Brönstrup, Mark; Gröbe, Lothar; Guerra, Giulia; Höltke, Alexander; Harmrolfs, Kirsten; Schiller, Lauritz; Tegge, Werner; Weich, Herbert; Wullenkord, Hannah; Xu, Chunfa [Angewandte Chemie - International Edition, 2021, vol. 60, # 33, p. 17989 - 17997][Angew. Chem., 2021, vol. 133, # 33, p. 18135 - 18144]
  • 38
  • (2S)-4-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid [ No CAS ]
  • [ 6089-09-4 ]
  • [ 929-10-2 ]
  • [ 71989-35-0 ]
  • [ 125238-99-5 ]
  • 1‐fluorenylmethoxycarbonyl-(2S,3aS,7aS)‐octahydroindole‐2‐carboxylic acid [ No CAS ]
  • [ 135112-27-5 ]
  • (2S)-2-[9H-fluorene-9-ylmethoxycarbonylamino]-4-methylsulfonylbutanoic acid [ No CAS ]
  • 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid [ No CAS ]
  • C68H101N9O16S [ No CAS ]
YieldReaction ConditionsOperation in experiment
Stage #1: (S)-4-tert-butoxycarbonylamino-2-(9H-fluoren-9-ylmethoxycarbonylamino)butyric acid With O‑(6‑chlorobezotriazol‑1‑yl)‑N,N,N,N‑tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h; Stage #2: With piperidine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 0.166667h; Stage #3: (2S)-4-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid; 4-pentynoic acid; isooctanoic acid; Fmoc-Thr(tBu)-OH; 1‐fluorenylmethoxycarbonyl-(2S,3aS,7aS)‐octahydroindole‐2‐carboxylic acid; (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)butanoic acid; (2S)-2-[9H-fluorene-9-ylmethoxycarbonylamino]-4-methylsulfonylbutanoic acid; 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid Further stages;
Reference： [1]Beutling, Ulrike; Brönstrup, Mark; Gröbe, Lothar; Guerra, Giulia; Höltke, Alexander; Harmrolfs, Kirsten; Schiller, Lauritz; Tegge, Werner; Weich, Herbert; Wullenkord, Hannah; Xu, Chunfa [Angewandte Chemie - International Edition, 2021, vol. 60, # 33, p. 17989 - 17997][Angew. Chem., 2021, vol. 133, # 33, p. 18135 - 18144]
  • 39
  • [ 235788-61-1 ]
  • [ 6089-09-4 ]
  • [ 929-10-2 ]
  • [ 35661-60-0 ]
  • [ 71989-35-0 ]
  • [ 114360-54-2 ]
  • [ 125238-99-5 ]
  • [ 130309-37-4 ]
  • [ 135112-27-5 ]
  • [ 163437-14-7 ]
  • [ 117666-96-3 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
Stage #1: Fmoc-Thr(tBu)-OH With O‑(6‑chlorobezotriazol‑1‑yl)‑N,N,N,N‑tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h; Stage #2: With piperidine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 0.166667h; Stage #3: (2S)-4-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid; 4-pentynoic acid; isooctanoic acid; Fmoc-Leu-OH; Fmoc-Thr(tBu)-OH; N-(9-fluorenylmethoxycarbonyl)-D-leucine; (S)-4-tert-butoxycarbonylamino-2-(9H-fluoren-9-ylmethoxycarbonylamino)butyric acid; 1‐fluorenylmethoxycarbonyl-(2S,3aS,7aS)‐octahydroindole‐2‐carboxylic acid; (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)butanoic acid; (2S)-2-[9H-fluorene-9-ylmethoxycarbonylamino]-4-methylsulfonylbutanoic acid; 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid Further stages;
Reference： [1]Beutling, Ulrike; Brönstrup, Mark; Gröbe, Lothar; Guerra, Giulia; Höltke, Alexander; Harmrolfs, Kirsten; Schiller, Lauritz; Tegge, Werner; Weich, Herbert; Wullenkord, Hannah; Xu, Chunfa [Angewandte Chemie - International Edition, 2021, vol. 60, # 33, p. 17989 - 17997][Angew. Chem., 2021, vol. 133, # 33, p. 18135 - 18144]
  • 40
  • [ 235788-61-1 ]
  • [ 6089-09-4 ]
  • [ 929-10-2 ]
  • [ 35661-60-0 ]
  • [ 71989-35-0 ]
  • [ 114360-54-2 ]
  • [ 125238-99-5 ]
  • [ 130309-37-4 ]
  • [ 135112-27-5 ]
  • [ 163437-14-7 ]
  • [ 117666-96-3 ]
  • [ 2823428-20-0 ]
YieldReaction ConditionsOperation in experiment
Stage #1: Fmoc-Thr(tBu)-OH With O‑(6‑chlorobezotriazol‑1‑yl)‑N,N,N,N‑tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h; Stage #2: With piperidine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 0.166667h; Stage #3: (2S)-4-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid; 4-pentynoic acid; isooctanoic acid; Fmoc-Leu-OH; Fmoc-Thr(tBu)-OH; N-(9-fluorenylmethoxycarbonyl)-D-leucine; (S)-4-tert-butoxycarbonylamino-2-(9H-fluoren-9-ylmethoxycarbonylamino)butyric acid; 1‐fluorenylmethoxycarbonyl-(2S,3aS,7aS)‐octahydroindole‐2‐carboxylic acid; (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)butanoic acid; (2S)-2-[9H-fluorene-9-ylmethoxycarbonylamino]-4-methylsulfonylbutanoic acid; 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid Further stages;
Reference： [1]Beutling, Ulrike; Brönstrup, Mark; Gröbe, Lothar; Guerra, Giulia; Höltke, Alexander; Harmrolfs, Kirsten; Schiller, Lauritz; Tegge, Werner; Weich, Herbert; Wullenkord, Hannah; Xu, Chunfa [Angewandte Chemie - International Edition, 2021, vol. 60, # 33, p. 17989 - 17997][Angew. Chem., 2021, vol. 133, # 33, p. 18135 - 18144]
  • 41
  • [ 235788-61-1 ]
  • [ 6089-09-4 ]
  • [ 929-10-2 ]
  • [ 35661-60-0 ]
  • [ 71989-35-0 ]
  • [ 114360-54-2 ]
  • [ 125238-99-5 ]
  • [ 130309-37-4 ]
  • [ 135112-27-5 ]
  • [ 163437-14-7 ]
  • [ 117666-96-3 ]
  • [ 2823428-24-4 ]
YieldReaction ConditionsOperation in experiment
Stage #1: Fmoc-Thr(tBu)-OH With O‑(6‑chlorobezotriazol‑1‑yl)‑N,N,N,N‑tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h; Stage #2: With piperidine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 0.166667h; Stage #3: (2S)-4-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid; 4-pentynoic acid; isooctanoic acid; Fmoc-Leu-OH; Fmoc-Thr(tBu)-OH; N-(9-fluorenylmethoxycarbonyl)-D-leucine; (S)-4-tert-butoxycarbonylamino-2-(9H-fluoren-9-ylmethoxycarbonylamino)butyric acid; 1‐fluorenylmethoxycarbonyl-(2S,3aS,7aS)‐octahydroindole‐2‐carboxylic acid; (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)butanoic acid; (2S)-2-[9H-fluorene-9-ylmethoxycarbonylamino]-4-methylsulfonylbutanoic acid; 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid Further stages;
Reference： [1]Beutling, Ulrike; Brönstrup, Mark; Gröbe, Lothar; Guerra, Giulia; Höltke, Alexander; Harmrolfs, Kirsten; Schiller, Lauritz; Tegge, Werner; Weich, Herbert; Wullenkord, Hannah; Xu, Chunfa [Angewandte Chemie - International Edition, 2021, vol. 60, # 33, p. 17989 - 17997][Angew. Chem., 2021, vol. 133, # 33, p. 18135 - 18144]
  • 42
  • [ 235788-61-1 ]
  • [ 6089-09-4 ]
  • [ 71989-35-0 ]
  • [ 130309-37-4 ]
  • [ 135112-27-5 ]
  • [ 163437-14-7 ]
  • [ 117666-96-3 ]
  • [ 2823428-43-7 ]
YieldReaction ConditionsOperation in experiment
Stage #1: Fmoc-Thr(tBu)-OH With O‑(6‑chlorobezotriazol‑1‑yl)‑N,N,N,N‑tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h; Stage #2: With piperidine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 0.166667h; Stage #3: (2S)-4-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid; 4-pentynoic acid; 1‐fluorenylmethoxycarbonyl-(2S,3aS,7aS)‐octahydroindole‐2‐carboxylic acid; (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)butanoic acid; (2S)-2-[9H-fluorene-9-ylmethoxycarbonylamino]-4-methylsulfonylbutanoic acid; 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid Further stages;
Reference： [1]Beutling, Ulrike; Brönstrup, Mark; Gröbe, Lothar; Guerra, Giulia; Höltke, Alexander; Harmrolfs, Kirsten; Schiller, Lauritz; Tegge, Werner; Weich, Herbert; Wullenkord, Hannah; Xu, Chunfa [Angewandte Chemie - International Edition, 2021, vol. 60, # 33, p. 17989 - 17997][Angew. Chem., 2021, vol. 133, # 33, p. 18135 - 18144]
  • 43
  • [ 235788-61-1 ]
  • [ 6089-09-4 ]
  • [ 71989-35-0 ]
  • [ 125238-99-5 ]
  • [ 130309-37-4 ]
  • [ 135112-27-5 ]
  • [ 163437-14-7 ]
  • [ 117666-96-3 ]
  • [ 2823428-39-1 ]
YieldReaction ConditionsOperation in experiment
Stage #1: Fmoc-Thr(tBu)-OH With O‑(6‑chlorobezotriazol‑1‑yl)‑N,N,N,N‑tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h; Stage #2: With piperidine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 0.166667h; Stage #3: (2S)-4-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid; 4-pentynoic acid; (S)-4-tert-butoxycarbonylamino-2-(9H-fluoren-9-ylmethoxycarbonylamino)butyric acid; 1‐fluorenylmethoxycarbonyl-(2S,3aS,7aS)‐octahydroindole‐2‐carboxylic acid; (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)butanoic acid; (2S)-2-[9H-fluorene-9-ylmethoxycarbonylamino]-4-methylsulfonylbutanoic acid; 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid Further stages;
Reference： [1]Beutling, Ulrike; Brönstrup, Mark; Gröbe, Lothar; Guerra, Giulia; Höltke, Alexander; Harmrolfs, Kirsten; Schiller, Lauritz; Tegge, Werner; Weich, Herbert; Wullenkord, Hannah; Xu, Chunfa [Angewandte Chemie - International Edition, 2021, vol. 60, # 33, p. 17989 - 17997][Angew. Chem., 2021, vol. 133, # 33, p. 18135 - 18144]
  • 44
  • [ 235788-61-1 ]
  • [ 6089-09-4 ]
  • [ 35661-60-0 ]
  • [ 71989-35-0 ]
  • [ 114360-54-2 ]
  • [ 125238-99-5 ]
  • [ 130309-37-4 ]
  • [ 135112-27-5 ]
  • [ 163437-14-7 ]
  • [ 117666-96-3 ]
  • [ 2823428-16-4 ]
YieldReaction ConditionsOperation in experiment
Stage #1: Fmoc-Thr(tBu)-OH With O‑(6‑chlorobezotriazol‑1‑yl)‑N,N,N,N‑tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h; Stage #2: With piperidine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 0.166667h; Stage #3: (2S)-4-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid; 4-pentynoic acid; Fmoc-Leu-OH; N-(9-fluorenylmethoxycarbonyl)-D-leucine; (S)-4-tert-butoxycarbonylamino-2-(9H-fluoren-9-ylmethoxycarbonylamino)butyric acid; 1‐fluorenylmethoxycarbonyl-(2S,3aS,7aS)‐octahydroindole‐2‐carboxylic acid; (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)butanoic acid; (2S)-2-[9H-fluorene-9-ylmethoxycarbonylamino]-4-methylsulfonylbutanoic acid; 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid Further stages;
Reference： [1]Beutling, Ulrike; Brönstrup, Mark; Gröbe, Lothar; Guerra, Giulia; Höltke, Alexander; Harmrolfs, Kirsten; Schiller, Lauritz; Tegge, Werner; Weich, Herbert; Wullenkord, Hannah; Xu, Chunfa [Angewandte Chemie - International Edition, 2021, vol. 60, # 33, p. 17989 - 17997][Angew. Chem., 2021, vol. 133, # 33, p. 18135 - 18144]
  • 45
  • [ 6089-09-4 ]
  • [ 130309-37-4 ]
  • [ 135112-27-5 ]
  • [ 163437-14-7 ]
  • [ 117666-96-3 ]
  • [ 2823427-84-3 ]
YieldReaction ConditionsOperation in experiment
16.7% Stage #1: (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)butanoic acid With O‑(6‑chlorobezotriazol‑1‑yl)‑N,N,N,N‑tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine at 20℃; for 2h; Stage #2: With piperidine In N,N-dimethyl-formamide at 20℃; for 0.166667h; Stage #3: 4-pentynoic acid; 1‐fluorenylmethoxycarbonyl-(2S,3aS,7aS)‐octahydroindole‐2‐carboxylic acid; (2S)-2-[9H-fluorene-9-ylmethoxycarbonylamino]-4-methylsulfonylbutanoic acid; 2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-benzoylphenyl)propanoic acid Further stages;
Reference： [1]Beutling, Ulrike; Brönstrup, Mark; Gröbe, Lothar; Guerra, Giulia; Höltke, Alexander; Harmrolfs, Kirsten; Schiller, Lauritz; Tegge, Werner; Weich, Herbert; Wullenkord, Hannah; Xu, Chunfa [Angewandte Chemie - International Edition, 2021, vol. 60, # 33, p. 17989 - 17997][Angew. Chem., 2021, vol. 133, # 33, p. 18135 - 18144]
Same Skeleton Products
Related Products
Historical Records

Related Functional Groups of
[ 117666-96-3 ]

Amino Acid Derivatives

Chemical Structure| 71989-20-3

[ 71989-20-3 ]

Fmoc-Gln-OH

Similarity: 0.92

Chemical Structure| 144701-24-6

[ 144701-24-6 ]

Fmoc-D-Nva-OH

Similarity: 0.92

Chemical Structure| 199110-64-0

[ 199110-64-0 ]

Fmoc-Bip(4,4')-OH

Similarity: 0.92

Chemical Structure| 205526-38-1

[ 205526-38-1 ]

Fmoc-D-Bip(4,4’)-OH

Similarity: 0.92

Chemical Structure| 204320-60-5

[ 204320-60-5 ]

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-methylhexanoic acid

Similarity: 0.92